Company Filing History:
2 out of 2,490 
2 out of 1,159 Years Active: 2011-2014
Title: Manfred Oberreither: Innovator in Vaccine Formulations
Introduction
Manfred Oberreither is a notable inventor based in Graz, Austria. He has made significant contributions to the field of vaccine formulations, particularly focusing on the stabilization of viral compositions. His work has implications for both vaccine development and therapeutic applications.
Latest Patents
Oberreither holds 2 patents related to vaccine formulations. His latest patents describe a liquid or liquid-frozen composition that includes a modified vaccinia Ankara (MVA) virus or its variants, combined with mannitol as the sole stabilization agent. This innovative formulation allows for stabilization at temperatures ranging from 0 to +10°C, as well as in liquid-frozen states between -10°C and -30°C or -20°C and -23.5°C. The MVA can be utilized as a vaccine or for applications in gene therapy, virotherapy, immunotherapy, or cancer therapy in mammals, particularly humans.
Career Highlights
Throughout his career, Oberreither has worked with prominent companies such as Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has contributed to his expertise in vaccine development and formulation.
Collaborations
Oberreither has collaborated with notable colleagues, including Christa Tauer and Falko-Guenter Falkner. These partnerships have likely enhanced his research and development efforts in the field of vaccine technology.
Conclusion
Manfred Oberreither's contributions to vaccine formulations demonstrate his innovative spirit and commitment to advancing medical science. His work continues to influence the development of effective vaccines and therapies.